LANYARD K DIAL
VENTURA, CA NPI 1629131545
Browse related groups: CA Acerta Pharma LLC All categories
General Payments — all program years on this page
$2,237.04
- Category: General Payments
- Program years: PY2018–2023
- Record count: 21
- As of (CMS publication): 2026-01-23
Latest program year (PY2023): $765.67 across 6 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2023) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $765.67 | 6 |
By paying entity
Latest program year (PY2023) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $226.10 | 2 |
| Edwards Lifesciences Corporation | $169.09 | 1 |
| Otsuka America Pharmaceutical, Inc. | $125.29 | 1 |
| Neurent Medical Limited | $125.00 | 1 |
| GlaxoSmithKline, LLC. | $120.19 | 1 |
By program year
Records — PY2023 (6)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1002317663 | GlaxoSmithKline, LLC. | $120.19 | 08/30/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1011708588 | AstraZeneca Pharmaceuticals LP | $120.15 | 06/30/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1014310413 | Otsuka America Pharmaceutical, Inc. | $125.29 | 10/24/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1016102467 | AstraZeneca Pharmaceuticals LP | $105.95 | 11/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1023152591 | Edwards Lifesciences Corporation | $169.09 | 05/17/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 993292211 | Neurent Medical Limited | $125.00 | 05/19/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.